Literature DB >> 16606904

Human African trypanosomiasis: in and out of Africa.

Peter G E Kennedy.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16606904     DOI： 10.1212/01.wnl.0000208221.55385.55

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  Enantiospecific reassessment of the pharmacokinetics and pharmacodynamics of oral eflornithine against late-stage Trypanosoma brucei gambiense sleeping sickness.

Authors:  R Jansson-Löfmark; K Na-Bangchang; S Björkman; F Doua; M Ashton
Journal:  Antimicrob Agents Chemother       Date:  2014-12-15       Impact factor: 5.191

2.  Enantioselective and nonlinear intestinal absorption of eflornithine in the rat.

Authors:  R Jansson; M Malm; C Roth; M Ashton
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

3.  Population Pharmacodynamic Modeling of Eflornithine-Based Treatments Against Late-Stage Gambiense Human African Trypanosomiasis and Efficacy Predictions of L-eflornithine-Based Therapy.

Authors:  Carl Amilon; Mikael Boberg; Joel Tarning; Angela Äbelö; Michael Ashton; Rasmus Jansson-Löfmark
Journal:  AAPS J       Date:  2022-03-25       Impact factor: 4.009
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.